Elevated circulating levels of serum talin1 are significantly associated with higher concentrations of total cholesterol and remnant cholesterol, as well as distinct adverse metabolic states characterized by hypercholesterolemic and atherogenic profiles, according to a cross-sectional study conducted among community-dwelling Chinese adults.
Dyslipidemia represents a major modifiable risk factor for the development of atherosclerosis and cardiovascular disease. Within cellular systems, talin1 serves as a cytoskeletal protein that is essential for integrin activation. Although experimental studies have implicated talin1 in various lipid-related biological processes, its functional role and clinical relationship with lipid metabolism have remained largely unclear in human populations. The present study was designed to clarify this association within an unselected community cohort.
The investigation analyzed cross-sectional data collected from 1,902 community members who were free of diagnosed cardiovascular disease at the time of examination. The study cohort had a mean age of 57.33 years and was comprised of 37.85 percent male participants.
To quantify biomarker levels, serum talin1 was measured using a commercial enzyme-linked immunosorbent assay (ELISA). In addition, the research protocol evaluated nine distinct indicators of lipid metabolism: conventional cholesterol metrics including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C); remnant cholesterol (RC); the non-HDL-C level; the low-density lipoprotein to high-density lipoprotein (LDL-HDL) ratio; the triglyceride-glucose (TyG) index; and the plasma atherogenic index (AIP).
To model the complex interactions across these nine indicators, the investigators performed latent profile analysis to stratify participants into discrete latent states of lipid metabolism. The statistical evaluation applied median regression models to test the continuous associations between serum talin1 levels and individual lipid measures. In parallel, logistic regression models were implemented to evaluate whether circulating talin1 was associated with categorized abnormal lipid profiles and overall latent metabolic status.
Analysis of the individual lipid indicators revealed that higher concentrations of serum talin1 were significantly associated with total cholesterol (beta = 0.16, P = 0.010) and remnant cholesterol (beta = 0.08, P < 0.001). In contrast, associations between serum talin1 and the other individual lipid markers were not statistically significant. When assessing risk of abnormal lipid metabolism, elevated serum talin1 was associated with a 67 percent greater risk of abnormal metabolism defined specifically by elevated remnant cholesterol (odds ratio = 1.67, 95 percent confidence interval: 1.25 to 2.25, P = 0.001), whereas definitions based on other lipid indicators yielded no statistically significant relationship (all P > 0.05).
Beyond single-marker analyses, latent profile analysis revealed that elevated serum talin1 levels were significantly associated with adverse holistic states of lipid metabolism. Specifically, higher serum talin1 was associated with an atherogenic state (odds ratio = 1.72, 95 percent confidence interval: 1.11 to 2.30, P = 0.017) and a hypercholesterolemic state (odds ratio = 1.63, 95 percent confidence interval: 1.16 to 2.31, P = 0.005). The authors concluded that serum talin1 is significantly associated with higher levels of total cholesterol and remnant cholesterol and serves as an indicator of adverse atherogenic and hypercholesterolemic metabolic states in Chinese adults, while emphasizing the cross-sectional scope of the analysis.
Elevated circulating levels of the cytoskeletal protein tracked significantly with remnant cholesterol and total cholesterol, but showed no statistically significant links with triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, the non-HDL-C level, the LDL-to-HDL ratio, the triglyceride-glucose index, or the plasma atherogenic index.
These observations help contextualize the clinical significance of talin1, which had previously been implicated in lipid processes primarily in experimental models rather than human cohorts. Because dyslipidemia represents a major modifiable risk factor for atherosclerosis and cardiovascular disease, establishing how serum talin1 aligns with adverse lipid states addresses a key question in cardiovascular health. Nevertheless, the study remains a cross-sectional analysis of 1,902 community-dwelling adults free of cardiovascular disease. The reported results therefore establish statistical associations with atherogenic and hypercholesterolemic states rather than proving causal mechanisms in lipid metabolism.
Subject of Research: Association between serum talin1 and lipid metabolism in Chinese adults
Article Title: Serum talin1 is associated with hypercholesterolemic and atherogenic states of lipid metabolism: results from latent profile analysis in Chinese adults
Article References: Meng, Y., Lu, F., Yu, X., Ji, L., Zhang, R., Yao, M., Duan, J., Du, M., Han, B., Wang, P., Guo, Q., Zhang, M., Xue, A., Wang, S., & Peng, H. (2026). Serum talin1 is associated with hypercholesterolemic and atherogenic states of lipid metabolism: results from latent profile analysis in Chinese adults. Lipids in Health and Disease. https://doi.org/10.1186/s12944-026-03094-y
Image Credits: AI Generated
DOI: 10.1186/s12944-026-03094-y
Keywords: talin1, serum talin1, lipid metabolism, dyslipidemia, atherosclerosis, cardiovascular disease, total cholesterol, remnant cholesterol, triglyceride-glucose index, plasma atherogenic index, latent profile analysis, median regression, logistic regression, cross-sectional study, hypercholesterolemia, integrin activation, non-HDL cholesterol, Chinese adults

